Clin Nutr Res.  2015 Jan;4(1):41-45. 10.7762/cnr.2015.4.1.41.

Diet, Sleep and Metabolic Syndrome Among a Legal Amazon Population, Brazil

• dos Santos PR
• Ferrari GS
• Ferrari CK

• KMID: 2049161
• DOI: http://doi.org/10.7762/cnr.2015.4.1.41

Abstract

Metabolic syndrome incidence is increasing worldwide then it is important to study the possible risk and protective factors. Our previous study suggested an association between coffee consumption and metabolic syndrome. The aim of this study was to address possible associations between dietary lifestyle factors with metabolic syndrome. In a case-control study we compared 74 metabolic syndrome patients with 176-matched controls attended at a public health central unit. Incident cases diagnosed according to ATP III criteria were matched with control group composed of healthy subjects performing routine examinations. Having lower educational level compared to highest levels tend to increase metabolic syndrome prevalence, which was not statistically significant. Similar pattern was observed for marital status. No difference was found regarding gender and metabolic syndrome odds. Interestingly, daily drinking two to three cups of coffee (OR=0.0646, 95% CI, 0.0139-0.3005, p=0.0005) or until 2 cups of milk were inversely associated with metabolic syndrome odds (OR=0.5368, 95% CI, 0.3139-0.9181, p=0.0231). Sleeping seven to eight hours per night was also associated with decreased odds of metabolic syndrome (OR=0.0789, 95% CI, 0.0396-0.1570, p<0.0001). Eating at least two portions of chocolate was also associated with decreased risk of metabolic syndrome (OR=0.3475, 95%CI, 0.1865-0.6414, p=0.0009). Adequate sleeping and dietary intake of some foods materially decreased the metabolic syndrome.

Keyword

Metabolic Syndrome X; Case-control studies; Chocolate; Milk; Coffee

MeSH Terms

Adenosine Triphosphate
Brazil*
Cacao
Case-Control Studies
Coffee
Diet*
Drinking
Eating
Humans
Incidence
Life Style
Marital Status
Metabolic Syndrome X
Milk
Prevalence
Public Health
Adenosine Triphosphate
Coffee

Reference

1. Bae YJ, Kim SH, Chung JH, Song SW, Kim KS, Kim MK, Kwon O, Choi MS, Sung MK. Evaluation of adiposity-related biomarkers as metabolic syndrome indicators. Clin Nutr Res. 2013; 2:91–99.

2. Comstock SS, Hortos K, Kovan B, McCaskey S, Pathak DR, Fenton JI. Adipokines and obesity are associated with colorectal polyps in adult males: a cross-sectional study. PLoS One. 2014; 9:e85939.

3. Shimizu M, Tanaka T, Moriwaki H. Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Semin Immunopathol. 2013; 35:191–202.

4. Häggström C, Rapp K, Stocks T, Manjer J, Bjørge T, Ulmer H, Engeland A, Almqvist M, Concin H, Selmer R, Ljungberg B, Tretli S, Nagel G, Hallmans G, Jonsson H, Stattin P. Metabolic factors associated with risk of renal cell carcinoma. PLoS One. 2013; 8:e57475.

5. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, Gaye A, Gögele M, Heier M, Hiekkalinna T, Joensuu A, Newby C, Pang C, Partinen E, Reischl E, Schwienbacher C, Tammesoo ML, Swertz MA, Burton P, Ferretti V, Fortier I, Giepmans L, Harris JR, Hillege HL, Holmen J, Jula A, Kootstra-Ros JE, Kvaløy K, Holmen TL, Männistö S, Metspalu A, Midthjell K, Murtagh MJ, Peters A, Pramstaller PP, Saaristo T, Salomaa V, Stolk RP, Uusitupa M, van der Harst P, van der Klauw MM, Waldenberger M, Perola M, Wolffenbuttel BH. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014; 14:9.

6. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008; 28:629–636.

7. Kim J, Bea W, Lee K, Han J, Kim S, Kim M, Na W, Sohn C. Effect of the telephone-delivered nutrition education on dietary intake and biochemical parameters in subjects with metabolic syndrome. Clin Nutr Res. 2013; 2:115–124.

8. Elwood PC, Pickering JE, Fehily AM. Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health. 2007; 61:695–698.

9. Fumeron F, Lamri A, Abi Khalil C, Jaziri R, Porchay-Baldérelli I, Lantieri O, Vol S, Balkau B, Marre M. Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study Group. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2011; 34:813–817.

10. Kwon HT, Lee CM, Park JH, Ko JA, Seong EJ, Park MS, Cho B. Milk intake and its association with metabolic syndrome in Korean: analysis of the third Korea National Health and Nutrition Examination Survey (KNHANES III). J Korean Med Sci. 2010; 25:1473–1479.

11. Wu MC, Yang YC, Wu JS, Wang RH, Lu FH, Chang CJ. Short sleep duration associated with a higher prevalence of metabolic syndrome in an apparently healthy population. Prev Med. 2012; 55:305–309.

12. Takami H, Nakamoto M, Uemura H, Katsuura S, Yamaguchi M, Hiyoshi M, Sawachika F, Juta T, Arisawa K. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol. 2013; 23:12–20.

13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735–2752.

14. Sá eNN, Moura EC. Factors associated with the burden of metabolic syndrome diseases among Brazilian adults. Cad Saude Publica. 2010; 26:1853–1862.

15. Dutra ES, de Carvalho KM, Miyazaki E, Hamann EM, Ito MK. Metabolic syndrome in central Brazil: prevalence and correlates in the adult population. Diabetol Metab Syndr. 2012; 4:20.

16. Fonseca AGA, David LA, Ferrari GS, Ferrari CK. Prevalência de síndrome metabólica em pacientes atendidos na estratégia de saúde da família de Barra do Garças, MT. J Med Biol Sci. 2012; 11:290–295.

17. Kratz M, Baars T, Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr. 2013; 52:1–24.

18. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010; 33:585–592.

19. Kobayashi D, Takahashi O, Deshpande GA, Shimbo T, Fukui T. Relation between metabolic syndrome and sleep duration in Japan: a large scale cross-sectional study. Intern Med. 2011; 50:103–107.

20. Chaput JP, McNeil J, Després JP, Bouchard C, Tremblay A. Seven to eight hours of sleep a night is associated with a lower prevalence of the metabolic syndrome and reduced overall cardiometabolic risk in adults. PLoS One. 2013; 8:e72832.

21. Colwell CS, Matveyenko AV. Timing is everything: implications for metabolic consequences of sleep restriction. Diabetes. 2014; 63:1826–1828.

22. Hjorth MF, Chaput JP, Damsgaard CT, Dalskov SM, Andersen R, Astrup A, Michaelsen KF, Tetens I, Ritz C, Sjödin A. Low physical activity level and short sleep duration are associated with an increased cardio-metabolic risk profile: a longitudinal study in 8-11 year old Danish children. PLoS One. 2014; 9:e104677.

23. Tufik S, Andersen ML, Bittencourt LR, Mello MT. Paradoxical sleep deprivation: neurochemical, hormonal and behavioral alterations. Evidence from 30 years of research. An Acad Bras Cienc. 2009; 81:521–538.

24. Abrahão SA, Pereira RG, de Sousa RV, Lima AR, Crema GP, Barros BS. Influence of coffee brew in metabolic syndrome and type 2 diabetes. Plant Foods Hum Nutr. 2013; 68:184–189.

25. Panchal SK, Wong WY, Kauter K, Ward LC, Brown L. Caffeine attenuates metabolic syndrome in diet-induced obese rats. Nutrition. 2012; 28:1055–1062.

26. Jia H, Aw W, Egashira K, Takahashi S, Aoyama S, Saito K, Kishimoto Y, Kato H. Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice. Genes Nutr. 2014; 9:389.

27. Takahashi S, Saito K, Jia H, Kato H. An integrated multi-omics study revealed metabolic alterations underlying the effects of coffee consumption. PLoS One. 2014; 9:e91134.

28. Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di Angelantonio E, Franco OH. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ. 2011; 343:d4488.

29. Tokede OA, Ellison CR, Pankow JS, North KE, Hunt SC, Kraja AT, Arnett DK, Djoussé L. Chocolate consumption and prevalence of metabolic syndrome in the NHLBI Family Heart Study. ESPEN J. 2012; 7:e139–e143.

30. Gu Y, Yu S, Lambert JD. Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice. Eur J Nutr. 2014; 53:149–158.

31. Andra-Iulia S, Laura M, Suceveanu A, Irinel P, Doina C, Paris S, Voinea F. The cardiometabolic benefits of flavonoids and dark chocolate intake in patients at risk. ARS Medica Tomitana. 2014; 20:14–18.